Katherine “Kat” Macfarlane, JD, who has rheumatoid arthritis and inflammatory eye disease, spoke at a briefing held at the House of Representatives on Monday about regulation of biosimilars.
Patient Advocate Cindi Brannum played a key role in the passing of Texas House Bill 751, which was signed into law by Governor Abbott on June 19th!
Please join the Coalition of State Rheumatology Organizations, the American
Autoimmune Related Diseases Association, the Global Healthy Living Foundation,
and the Arthritis Foundation, in cooperation with the Congressional Arthritis
Caucus, for a briefing on implementation of the Biologics Price Competition and
(Upper Nyack, NY) The Global Healthy Living Foundation, working with the Coalition of State Rheumatology Organizations (CRSO) and the Arthritis Foundation, in cooperation with the Congressional Arthritis Caucus, will co-host a congressional briefing to address the forthcoming availability of biosimilars in light of the U.S. Food and Drug Administration (FDA) not providing final guidance […]
Rheumatoid arthritis patient advocates for continued access to medication in North Dakota